Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 16 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 10420811

    Cultivation of selenium-rich Cyclocarya paliurus plant, extraction and use of active ingredients thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  2. US 10413580

    Compositions comprising Cyclocarya paliurus extract and preparation method and uses thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  3. US 10407403

    Preparation method of cobimetinib

    Suzhou Miracpharma Technology Co., Ltd. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted
  4. US 10406194

    Powder formulation, method for preparing the same and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted
  5. US 10398762

    Methods and compositions for treating diabetes

    Oramed Ltd. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted
  6. US 10376552

    Memory improving composition comprising arillus longan, semen nelumbinis, poria and semen juglandis

    INFINITUS (CHINA) COMPANY LTD. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  7. US 10369184

    Composition and use thereof in manufacture of product for improving intestinal function

    INFINITUS (CHINA) COMPANY LTD. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  8. US 10370380

    Octahydropyrrolo[3,4-c]pyrrole derivatives and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  9. US 10357453

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    O.D. Ocular Discovery Ltd. · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted
  10. US 10351598

    Peptide with anti-obesity and anti-diabetic efficacy and use thereof

    CAREGEN CO., LTD. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  11. US 10351597

    Peptide with anti-obesity and anti-diabetes activity and use thereof

    CAREGEN CO., LTD. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  12. US 10350162

    Methods and compositions for oral administration of exenatide

    Oramed Ltd. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  13. US 10344061

    Peptide exhibiting hair growth promoting activity and/or melanin production promoting activity and use thereof

    CAREGEN CO., LTD. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted
  14. US 10342764

    Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same

    Oramed Ltd. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted
  15. US 10321689

    Antimicrobial traditional Chinese medicine composition, and preparation method and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  16. US 10322129

    Therapeutic compositions containing dipyridamole, treatment packs and kits including such compositions and methods for producing same

    O.D. Ocular Discovery Ltd. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  17. US 10316025

    Substituted piperazine compounds and methods of use and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  18. US 10314769

    Organic-inorganic composite particles and cosmetic product

    JGC Catalysts and Chemicals Ltd. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  19. US 10307449

    Compositions of polymeric myrcene

    REGENERA PHARMA LTD. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted
  20. US 10307418

    Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds

    Platform Brightworks Two, Ltd. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted
  21. US 10308658

    Salt of EGFR inhibitor, crystalline form and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted
  22. US 10292940

    Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof

    BrightGene Bio-Medical Technology Co., Ltd. · Granted May 21, 2019 · Expires May 16, 2039

    granted
  23. US 10285996

    Compositions comprising triterpenoids

    REGENERA PHARMA LTD. · Granted May 14, 2019 · Expires May 9, 2039

    granted
  24. US 10280414

    Stabilized α-galactosidase and uses thereof

    Protalix Ltd. · Granted May 7, 2019 · Expires May 2, 2039

    granted